Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients

Australian Dental Journal

Volumn 55, Issue 4, 2010, Pages 405-410

  Ozcaka O ^a   Nalbantsoy, A ^a   Kose T ^a   Buduneli, N ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Chronic periodontitis; ELISA; osteoprotegerin; plasma; RANKL; smoking

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; OSTEOCLAST; SMOKING; STATISTICAL ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 78650168561     PISSN: 00450421     EISSN: 18347819     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2010.01261.x     Document Type: Article

References (34)

1. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL,. Evidence for cigarette smoking as a major risk factor periodontitis. J Periodontol 1993; 64: 16-23.
2. Calsina G, Ramon JM, Echeverria JJ,. Effects of smoking on periodontal tissues. J Clin Periodontol 2002; 29: 771-776.
3. Preber H, Bergström J, Linder LE,. Occurrence of periopathogens in smoker and non-smoker patients. J Clin Periodontol 1992; 19: 667-671.
4. Buduneli N, Baylas H, Buduneli E, Türkoǧlu O, Dahlen G,. Evaluation of the relationship between smoking during pregnancy and subgingival microbiota. J Clin Periodontol 2005; 32: 68-74.
5. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF,. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci 1995; 88: 485-489.
6. Boström L, Linder LE, Bergström J,. Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease. J Clin Periodontol 1999; 26: 352-357.
7. Rawlinson A, Grummitt JM, Walsh TF, Douglas CWI,. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 2003; 30: 42-48.
8. Buduneli N, Buduneli E, Kardeşler L, Lappin D, Kinane DF,. Plasminogen activator system in smokers and non-smokers with and without periodontal disease. J Clin Periodontol 2005; 32: 417-424.
9. Buduneli N, Kardeşler L, Işik H, et al., Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 2006; 33: 159-164.
10. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ,. Modulation of osteoclast differentaition and function by the new members of the tumour necrosis factor receptor and ligand families. Endoc Rev 1999; 20: 345-357.
11. Yasuda H, Shima N, Nakagawa N, et al., Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci (USA) 1998; 95: 3597-3602.
12. Quinn JMW, Horwood NJ, Elliott J, Gillespie MT, Martin TJ,. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 2000; 15: 1459-1466.
13. Horwood NJ, Kartsogiannis V, Quinn JMW, Romas E, Martin TJ, Gillespie MT,. Activated T lymphoctes support osteoclast formation in vitro. Biochem Biophys Res Commun 1999; 265: 144-150.
14. Lacey DL, Timms E, Tan H-L, et al., Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-176.
15. Kong YY, Yoshida H, Sarosi I, et al., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397: 315-323.
16. Mogi M, Otogoto J, Ota N, Togari A,. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004; 83: 166-169.
17. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J,. Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol 2004; 75: 1586-1591.
18. Lu H-K, Chen Y-L, Chang H-C, Li C-L, Kuo MY-P,. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodont Res 2006; 41: 354-360.
19. Bostanci N, İlgenli T, Emingil G, et al., Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007; 34: 370-376.
20. Arikan F, Lappin DF, Buduneli N,. C-telopeptide pyridinoline cross-links of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis. Int J Oral Maxillo Implants 2010 (in press).
21. Buduneli N, Biyikoǧlu B, Sherrabeh S, Lappin D,. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol 2008; 35: 846-852.
22. Arikan F, Buduneli N, Kütükçüler N,. Osteoprotegerin levels in peri-implant crevicular fluid. Clin Oral Implants Res 2008; 19: 283-288.
23. Armitage GC,. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1-6.
24. Hsu H, Lacey DL, Dunstan CR, et al., Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci (USA) 1999; 96: 3540-3545.
25. Simonet WS, Lacey DL, Dunstan CR, et al., Osteoprotegerin: a novel-secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319.
26. Kim SM, Lee J, Ryu OH, et al., Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol (Oxf) 2005; 63: 594-598.
27. Grossi SG, Zambon JJ, Ho AW, et al., Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994; 65: 260-267.
28. Grossi SG, Genco RJ, Machtei EE, Ho AW, Koch G, Dunford R,. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66: 23-29.
29. Tanaka H, Tanabe N, Shoji M, et al., Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sci 2006; 78: 1733-1740.
30. Apatzidou DA, Riggio MP, Kinane DF,. Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. J Clin Periodontol 2005; 32: 973-983.
31. Lappin DF, Sherrabeh S, Jenkins WM, Macpherson LM,. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. J Clin Periodontol 2007; 34: 271-277.
32. Crotti T, Smith MD, Hirsch R, et al., Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodont Res 2003; 38: 380-387.
33. Darby IB, Hodge PJ, Riggio MP, Kinane DF,. Clinical and microbiological effect of scaling and root planing in smoker and non-smoker chronic and aggressive periodontitis patients. J Clin Periodontol 2005; 32: 200-206.
34. Tang TH, Fitzsimmons TR, Bartold PM,. Effect of smoking on concentrations of receptor activator of nuclear factor κB ligand and osteoprotegerin in human gingival crevicular fluid. J Clin Periodontol 2009; 36: 713-718.